Drug Side Effects
Search
IMPLANT SITE THROMBOSIS
IMPLANT SITE THROMBOSIS
was reported 38 times
These drug classes are most commonly taken by patients reporting IMPLANT SITE THROMBOSIS:
#
Drug
Count
0
Progestin [EPC]
9
1
Benzodiazepine [EPC]
3
2
Nonsteroidal Anti-inflammatory Drug [EPC]
3
3
Platinum-based Drug [EPC]
3
4
Factor Xa Inhibitor [EPC]
2
5
HER2/neu Receptor Antagonist [EPC]
2
6
Loop Diuretic [EPC]
2
7
Tumor Necrosis Factor Blocker [EPC]
2
8
Vitamin C [EPC]
2
9
Aldosterone Antagonist [EPC]
1
10
Alkylating Drug [EPC]
1
11
Angiotensin 2 Receptor Blocker [EPC]
1
12
Aromatase Inhibitor [EPC]
1
13
Atypical Antipsychotic [EPC]
1
14
Cholinergic Muscarinic Antagonist [EPC]
1
15
Corticosteroid [EPC]
1
16
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
17
Estrogen Receptor Antagonist [EPC]
1
18
Expectorant [EPC]
1
19
Folate Analog Metabolic Inhibitor [EPC]
1
20
HMG-CoA Reductase Inhibitor [EPC]
1
21
Histamine-2 Receptor Antagonist [EPC]
1
22
Human C1 Esterase Inhibitor [EPC]
1
23
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]
1
24
Janus Kinase Inhibitor [EPC]
1
25
Microtubule Inhibitor [EPC]
1
26
Nitroimidazole Antimicrobial [EPC]
1
27
Nucleoside Metabolic Inhibitor [EPC]
1
28
Parathyroid Hormone Analog [EPC]
1
29
Peroxisome Proliferator Receptor alpha Agonist [EPC]
1
30
Proton Pump Inhibitor [EPC]
1
31
Purine Antimetabolite [EPC]
1
32
Substance P/Neurokinin-1 Receptor Antagonist [EPC]
1
33
Sulfonamide Antimicrobial [EPC]
1
34
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
35
beta3-Adrenergic Agonist [EPC]
1